Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Flocor enters phase I for ACS

Jan. 8, 1998

Heparinase III efficacy established in preclinical model

Jan. 8, 1998

PLC Systems submits requested data related to Heart Laser PMA

Jan. 7, 1998

Warner-Lambert develops new ET antagonists

Jan. 7, 1998

Taiho describes compounds for post-PTCA restenosis

Jan. 7, 1998

Tanabe Seiyaku patents new ACAT and lipid peroxidation inhibitors

Jan. 7, 1998

GR-144053 enhances suppression of neointima formation by losartan following vascular injury

Jan. 5, 1998

NOS inhibitors prepared at Ono

Jan. 5, 1998

Warner-Lambert describes water-soluble, nonpeptide ET antagonists

Jan. 2, 1998

New orally active antihypertensive compounds prepared at Rotta

Dec. 31, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...